Active substance
Results for the substance volanesorsen
1 result
About this active substance
Volanesorsen is a medication used for the treatment of patients with familial chylomicronemia syndrome (FCS), a rare genetic disorder characterized by extremely high levels of triglycerides in the blood. This condition can lead to severe complications such as acute pancreatitis. Volanesorsen is an antisense oligonucleotide that works by reducing the production of apolipoprotein C-III (ApoC-III), a protein involved in the regulation of triglyceride metabolism.
The medication is administered via subcutaneous injection, usually once a week, and treatment requires regular monitoring to assess efficacy and safety.
Common side effects include injection site reactions, thrombocytopenia (low platelet count), fatigue, and nausea. In rare cases, severe adverse reactions such as bleeding or allergic reactions may occur.
Patients receiving volanesorsen should be regularly monitored for platelet levels and signs of adverse reactions. The medication represents an important therapeutic option for patients with FCS, helping to reduce triglyceride levels and prevent associated complications.
The medication is administered via subcutaneous injection, usually once a week, and treatment requires regular monitoring to assess efficacy and safety.
Common side effects include injection site reactions, thrombocytopenia (low platelet count), fatigue, and nausea. In rare cases, severe adverse reactions such as bleeding or allergic reactions may occur.
Patients receiving volanesorsen should be regularly monitored for platelet levels and signs of adverse reactions. The medication represents an important therapeutic option for patients with FCS, helping to reduce triglyceride levels and prevent associated complications.